ARKG vs. CLIX
ARKG (ARK Genomic Revolution Multi-Sector ETF) and CLIX (ProShares Long Online/Short Stores ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while CLIX is a Long-Short fund tracking the ProShares Long Online/Short Stores Index. ARKG is actively managed, while CLIX is passively managed. Over the past 5 years, ARKG returned -14.83%/yr vs -8.13%/yr for CLIX. A 0.60 correlation means they provide meaningful diversification when combined. ARKG charges 0.75%/yr vs 0.65%/yr for CLIX.
Performance
ARKG vs. CLIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 38.45% return, which is significantly higher than CLIX's -10.00% return.
ARKG
- 1D
- 3.97%
- 1M
- 28.15%
- YTD
- 38.45%
- 6M
- 32.90%
- 1Y
- 65.40%
- 3Y*
- 7.15%
- 5Y*
- -14.83%
- 10Y*
- 10.24%
CLIX
- 1D
- -1.89%
- 1M
- -7.89%
- YTD
- -10.00%
- 6M
- -9.83%
- 1Y
- 6.38%
- 3Y*
- 17.52%
- 5Y*
- -8.13%
- 10Y*
- —
ARKG vs. CLIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 38.45% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 2.84% |
CLIX ProShares Long Online/Short Stores ETF | -10.00% | 32.81% | 20.73% | 28.97% | -46.73% | -39.96% | 90.91% | 17.32% | 6.34% | -2.43% |
Correlation
The correlation between ARKG and CLIX is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Nov 16, 2017 | 0.60 |
The correlation between ARKG and CLIX shifts across timeframes, from 0.46 (1 year) to 0.63 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. CLIX — Risk / Return Rank
ARKG
CLIX
ARKG vs. CLIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ProShares Long Online/Short Stores ETF (CLIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKG | CLIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.22 | ||
| Sortino ratioReturn per unit of downside risk | +1.67 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.07 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.39 | 0.33 | +2.06 |
| Martin ratioReturn relative to average drawdown | 5.69 | 0.83 | +4.86 |
Loading charts...
Drawdowns
ARKG vs. CLIX - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than CLIX's maximum drawdown of -73.21%. Use the drawdown chart below to compare losses from any high point for ARKG and CLIX.
Loading charts...
Drawdown Indicators
| ARKG | CLIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -73.21% | -10.38% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -19.57% | -7.94% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | -21.18% | -30.78% |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | -68.22% | -11.96% |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -64.11% | -46.83% | -17.28% |
Average DrawdownAverage peak-to-trough decline | -36.04% | -34.76% | -1.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.53% | 7.69% | +3.84% |
Volatility
ARKG vs. CLIX - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 16.58% compared to ProShares Long Online/Short Stores ETF (CLIX) at 6.73%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than CLIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | CLIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.58% | 6.73% | +9.85% |
Volatility (6M)Calculated over the trailing 6-month period | 31.63% | 16.40% | +15.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.20% | 21.46% | +21.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.07% | 27.05% | +19.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.35% | 25.92% | +15.43% |
ARKG vs. CLIX - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than CLIX's 0.65% expense ratio.
Dividends
ARKG vs. CLIX - Dividend Comparison
ARKG has not paid dividends to shareholders, while CLIX's dividend yield for the trailing twelve months is around 0.58%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
CLIX ProShares Long Online/Short Stores ETF | 0.58% | 0.46% | 0.46% | 0.00% | 0.00% | 0.00% | 1.33% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG and CLIX have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (16.58%) compared to CLIX (6.73%). In terms of maximum drawdown, ARKG dropped -83.59% vs CLIX's -73.21%.
On 5-year performance, CLIX leads with -8.13% vs -14.83% for ARKG. On fees, CLIX is cheaper at 0.65% per year. On volatility, CLIX has been the lower-risk option at 6.73%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, CLIX has performed better with a -8.13% return vs -14.83%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CLIX is cheaper with a 0.65% expense ratio, compared with 0.75% for ARKG.
CLIX has the higher dividend yield at 0.58%, compared with 0.00% for ARKG.
ARKG is categorized as Health & Biotech Equities, while CLIX is Long-Short. They also come from different issuers: ARK and ProShares. Their fees differ too: 0.75% for ARKG and 0.65% for CLIX.
ARKG currently has the higher Sharpe Ratio (1.52 vs 0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and CLIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer